Successful Administration of Cemiplimab to a Patient With Advanced Cutaneous Squamous Cell Carcinoma After Renal Transplantation

被引：12
|
作者：
Ali, Saad Ahmad [1 ]
Arman, Huseyin Emre [1 ]
Patel, Anuj Amrut [2 ]
Birhiray, Ruemu Ejedafeta [3 ]
机构：
[1] Marian Univ, Coll Osteopath Med, Indianapolis, IN USA
[2] Northwest Radiol, Indianapolis, IN USA
[3] Hematol Oncol Indiana, 8550 Naab Rd,Suite 205, Indianapolis, IN 46260 USA
来源：
JCO ONCOLOGY PRACTICE | 2020年 / 16卷 / 03期
关键词：
SKIN-CANCER; RECIPIENTS;
D O I：
10.1200/JOP.19.00567
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：137 / +
页数：3
相关论文
共 50 条
  • [21] Treatment of Unresectable Cutaneous Squamous Cell Carcinoma with Cemiplimab in a Patient on Dialysis
    de Lima, Stacy Grace
    Hyrcza, Martin D.
    Monzon, Jose Gerard
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 143 - 148
  • [22] Safety of cemiplimab for advanced cutaneous squamous cell carcinoma in a patient with p-ANCA-associated vasculitis
    Pham, James P.
    Sivasubramaniam, Vanathi
    Gallagher, Richard
    Forstner, Dion
    Wong, Muh
    Liu, Jia
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (03) : E363 - E365
  • [23] Value of cemiplimab in progressive metastatic cutaneous squamous cell carcinoma after kidney transplantation: a case report
    Geidel, G.
    Ruenger, A.
    Schneider, S. W.
    Gebhardt, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 : 49 - 52
  • [24] Real-World Experience With Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
    Strum, Scott
    Climans, Seth
    Purcell, Victoria
    Black, Morgan
    Winquist, Eric
    Ernst, Scott
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024,
  • [25] Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome
    Proietti, Ilaria
    Tolino, Ersilia
    Bernardini, Nicoletta
    Di Fraia, Marco
    Skroza, Nevena
    Potenza, Concetta
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2023, 13 (03):
  • [26] A Novel Intersection: Cytomegalovirus Gastritis Following Cemiplimab and Talimogene Laherparepvec in a Patient With Advanced Cutaneous Squamous Cell Carcinoma
    Egoryan, Goar
    Zimmet, Alex
    Yu, Mingwei
    Pozdol, Joseph
    Subramanian, Aruna
    Reddy, Sunil
    Nelson, Joanna
    CLINICAL CASE REPORTS, 2024, 12 (12):
  • [27] Prompt response of advanced cutaneous squamous cell carcinoma to cemiplimab in a kidney transplant patient receiving treatment with everolimus
    Gambichler, T.
    Hessam, S.
    Luettringhaus, T.
    Boms, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (03) : 608 - 609
  • [28] PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
    Migden, M. R.
    Rischin, D.
    Schmults, C. D.
    Guminski, A.
    Hauschild, A.
    Lewis, K. D.
    Chung, C. H.
    Hernandez-Aya, L.
    Lim, A. M.
    Chang, A. L. S.
    Rabinowits, G.
    Thai, A. A.
    Dunn, L. A.
    Hughes, B. G. M.
    Khushalani, N. I.
    Modi, B.
    Schadendorf, D.
    Gao, B.
    Seebach, F.
    Li, S.
    Li, J.
    Mathias, M.
    Booth, J.
    Mohan, K.
    Stankevich, E.
    Babiker, H. M.
    Brana, I.
    Gil-Martin, M.
    Homsi, J.
    Johnson, M. L.
    Moreno, V.
    Niu, J.
    Owonikoko, T. K.
    Papadopoulos, K. P.
    Yancopoulos, G. D.
    Lowy, I.
    Fury, M. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04): : 341 - 351
  • [29] Cemiplimab as first intervention for patients with locally advanced cutaneous squamous cell carcinoma.
    Atlas, Jennifer Lynn
    Kanos, Marina
    Symanowski, James Thomas
    Brickman, Daniel
    Forster, Meghan
    Frenkel, Catherine
    Milas, Zvonimir
    Sarantou, Terry
    White, Richard L.
    Amin, Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Clinical and histopathological features of advanced cutaneous squamous cell carcinoma with varying responses to cemiplimab
    Hempel, Conrad
    Vladimirova, Gabriela
    Horn, Susanne
    Horn, Lars-Christian
    Ziemer, Mirjana
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2025, 23 (01): : 30 - 37
12345